🇺🇸 FDA
Patent

US 11623011

Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo

granted A61KA61K47/61A61K47/6939

Quick answer

US patent 11623011 (Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo) held by ENGENE, INC. expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ENGENE, INC.
Grant date
Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K47/61, A61K47/6939, A61K9/5161, A61P